Notorious for not sticking to schedule, Elon Musk announces that Neuralink's show and tell event is postponed until November 30.
Musk takes Twitter to say that the much-awaited event will have to be pushed back by a month from originally being scheduled for October 31, Reuters writes.
No Further Information Has Been Provided Yet
Merely a week before the anticipated event promised for Musk's artificial intelligence company, the CEO tells the public that they might have to wait for Neuralink's show and tell a little longer.
Neuralink, a company started by the Tesla CEO in 2016, has the goal of creating an artificial intelligence device that can be implanted.
This technology will allow humans to directly interact with computers using their brain, rather than through traditional input methods, CNet says.
Musk claims that this project will be able to help humanity keep advancing in the development of artificial intelligence, with a focus on restoring the capabilities of people with disabilities.
However, Neuralink has yet to secure regulatory approval from the Food and Drug Administration, which hinders them from beginning human trials as the company suggests.
In 2020 and 2021, Neuralink tested on pigs and monkeys, but Musk has been dissatisfied with the results of those experiments.
Nevertheless, Engadget reports that the show and tell next month might reveal crucial information about the project, which must have been the reason why the company needs more preparation time.
Musk's Neuralink Faces Mixed Receptions From The Public
The multimillionaire believes that Neuralink will soon make it possible to save humans' memories in a chip, which will make them downloadable into another body or into a robot.
The Street writes that with the continuous development of Neuralink, the artificial intelligence product can provide a better understanding of neurological diseases in the future.
In the beginning, Gertude, a young sow, was the center of the Neuralink progress tests, where the animal was implanted with an 8 millimeter chip in its brain to observe cerebral activity.
However, the public is torn with the company's use of animals for testing in the industry because the tests have not been well-received by some of test subjects under experimentation, Tech Times says.
"The use of every animal was extensively planned and considered to balance scientific discovery with the ethical use of animals," the company says.
Neuralink defends itself by saying that the animals that were euthanized were necessary to gather important historical data, while others were let go as per the advice of veterinary staff.
With its Food and Drug Administration regulatory approval still pending, Neuralink has fallen behind its competition Synchron, which has tested its chips on humans in 2021.
Synchron is a brain-machine interface technology tested in Australia that can be installed in the brain without having to cut the skull open.
This technology aims to make life easier for people who have been paralyzed by offering them a way to control electronic devices through brain signals.
According to The Street, with the delay in Neuralink's regulation and development, Musk is reportedly talking with Synchron about possibly investing in the company.
Related Article: Elon Musk's Neuralink to Hold a 'Show and Tell' Event on October 31
